http://rdf.ncbi.nlm.nih.gov/pubchem/patent/RU-2014101626-A
Outgoing Links
| Predicate | Object |
|---|---|
| classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D417-14 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P35-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P35-02 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-4439 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P43-00 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D417-14 |
| filingDate | 2012-06-19-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationDate | 2015-07-27-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | RU-2014101626-A |
| titleOfInvention | POLYMORPHES 2-AMID 1 - ({4-METHYL-5- [2- (2, 2, 2-TRIFTOR-1, 1-DIMETHYL-Ethyl) -PYridIN-4-IL] THIAZOL-2-IL} AMIDE) ( S) -pyrrolidine-1, 2-dicarboxylic acid |
| abstract | 1. The crystalline form of a compound of formula I or a solvate of a crystalline form of a compound of formula I, or a salt of a crystalline form of a compound of formula I, or a solvate of a salt of a crystalline form of a compound of formula I.2. A compound according to claim 1, having a polymorphic form S, wherein the polymorph is characterized by a powder X-ray diffraction pattern having characteristic peaks expressed in degrees of 2-theta angle of 16.9 ° +/- 0.3 ° and 17.7 ° +/- 0.3 ° .3. A compound according to claim 2, wherein the polymorphic form S is characterized by a powder X-ray diffraction pattern having characteristic peaks expressed in degrees of 2-theta angle of 16.9 ° +/- 0.3 °, 17.7 ° +/- 0.3 °, 13, 3 ° +/- 0.3 °, 18.2 ° +/- 0.3 °, 20.3 ° +/- 0.3 ° and 16.5 ° +/- 0.3 °. 4. A compound according to claim 2, wherein the polymorph is characterized by a powder X-ray diffraction substantially in accordance with FIG. IV and Table 2.5. The compound according to claim 1, having a polymorphic form S, where the polymorph is characterized by a powder x-ray having characteristic peaks expressed in degrees of 2-theta angle of 13.2 ° +/- 0.3 ° and 18.3 ° +/- 0.3 ° .6. A compound according to claim 5, wherein the polymorphic form S is characterized by a powder X-ray diffraction pattern having characteristic peaks expressed in degrees of 2-theta angle of 13.2 ° +/- 0.3 °, 18.3 ° +/- 0.3 °, 17, 0 ° +/- 0.3 °, 15.7 ° +/- 0.3 °, 20.4 ° +/- 0.3 ° and 16.4 ° +/- 0.3 °. 7. A compound according to claim 5, wherein the polymorph is characterized by a powder X-ray diffraction substantially in accordance with FIG. V and Table 3.8. The compound according to claim 1, having a polymorphic form S, where the polymorph is characterized by a powder x-ray having characteristic peaks expressed in degrees of 2-theta angle of 17.0 ° +/- 0.3 ° and 18.2 ° +/- 0.3 ° .9. The compound of claim 8, wherein the polymorphic form S is characterized by a powder X-ray diffraction pattern having characteristic peaks expressed in degrees of 2-theta angle of 17.0 ° +/- |
| priorityDate | 2011-06-21-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
| Predicate | Subject |
|---|---|
| isDiscussedBy | http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID421399366 http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID18648965 |
Total number of triples: 15.